The 41st Annual Arthur L. Benton Lecture
John DeLuca, PhD, ABPP
Fatigue: What is it, Can we measure it, and Can we treat it?
IN-PERSON AND VIRTUAL EVENT
IN-PERSON ATTENDANCE: WILL BE CAPPED AT 70
(bring ID to enter)
LOCATION:
Manhattan Eye, Ear & Throat Hospital
210 E. 64th Street
New York, New York 10065
*Members: Free attendance & Free 1.0 CE credit
*Non-members: $30, which includes 1.0 CE credit
Abstract: Fatigue is a multi-faceted symptom, which is both pervasive and persistent. It affects ~20% of the general population and is a particular problem following neurological disease or infection. For instance, as many as 90% of individuals with multiple sclerosis report fatigue to be their worst symptom. Similarly, following viral infection such as COVID-19, ~40% of patients report elevated levels of fatigue. However, despite its prevalence, fatigue remains poorly understood. This is due, in large part, to an historical reliance on self-report measures to assess fatigue. This talk will trace the history of fatigue, explore ideas about how it is defined, assessed and treated. This presentation will discuss how fatigue is beginning to be understood through the use of rigorous experimental design and novel objective metrics such as signal detection theory and neuroimaging. New research-based approaches for treatment of fatigue will be discussed.
John DeLuca, PhD, is the Senior Vice President for Research and Training at Kessler Foundation, a Professor in the Department of Physical Medicine & Rehabilitation, and the Department of Neurology at Rutgers, New Jersey Medical School. He is board certified in Rehabilitation Psychology by the American Board of Professional Psychology. Dr. DeLuca has been involved in neuropsychology and rehabilitation research for over 30 years. He is internationally known for his research on disorders of memory and information processing in a variety of clinical populations including: multiple sclerosis, traumatic brain injury, aneurysmal subarachnoid hemorrhage, and chronic fatigue syndrome. Dr. DeLuca has published over 425 articles, books and book chapters in these areas, has edited 7 books in neuropsychology, neuroimaging and rehabilitation, and is a co-Chief editor for the “Encyclopedia of Clinical Neuropsychology.” He has received over 65 million dollars in grant support for his research. Dr. DeLuca's most recent research ventures include the cerebral mapping of human cognitive processes using functional neuroimaging, as well as the development of research-based techniques to improve cognitive impairment. He serves on the editorial boards of many journals and has received numerous national and international awards in recognition of his work.
Learning Objectives:
1. Understand the challenges with measuring and assessing fatigue.
2. Have a better understanding of the impact on fatigue and performance.
3. Have a better understanding of the relationship between fatigue and the brain.
Financial Disclosures: Dr. DeLuca serves(ed) on an Advisory board for: Biogen, Novartis, Celgene/BMS, Roche, Janssen, MedRhythms. He Serves(ed) as a Consultant for: Celgene/BMS, Sanofi – Genzyme. He serves(ed) on a Speakers Bureau for: Biogen, EMD Serono, Sanofi – Genzyme. He has received funding from: Biogen, EMD Serono, Roche, BMS, NMSS, CMSC, NIH, MS Society of Canada.
References:
*New York Neuropsychology Group is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0107
*New York Neuropsychology Group is approved by the American Psychological Association to sponsor continuing education for psychologists. NYNG maintains responsibility for this program and its content.
Refund Policy: Full refund will be provided if cancellation occurs up to 24 hours prior to the event. Cancellation requests made within 24 hours are non-refundable.
© 2020 New York Neuropsychology Group
.jpeg)